Showing results (31-40 of 65) with videos related to
Sort By:
Pageof 7
Journal of Pharmaceutical and Biomedical Analysis|February 27, 2022
In-depth characterization of phenolic profiling of Moraiolo extra-virgin olive oil extract and initial investigation of the inhibitory effect on Indoleamine-2,3-Dioxygenase (IDO1) enzymeFederica Ianni, Claudia Volpi, Simone Moretti, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressantCiriana Orabona, Maria Laura Belladonna, Carmine Vacca, et al.Analytical Chemistry|January 18, 2024
MARS: A Multipurpose Software for Untargeted LC-MS-Based Metabolomics and ExposomicsLaura Goracci, Paolo Tiberi, Stefano Di Bona, et al.Medchemcomm|August 16, 2018
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistryAlice Coletti, Francesco Antonio Greco, Daniela Dolciami, et al.Elife|June 30, 2023
A back-door insight into the modulation of Src kinase activity by the polyamine spermidineSofia Rossini, Marco Gargaro, Giulia Scalisi, et al.European Journal of Immunology|October 6, 2005
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12Ciriana Orabona, Elena Tomasello, Francesca Fallarino, et al.Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesisCiriana Orabona, Maria T Pallotta, Claudia Volpi, et al.Transplantation|August 19, 2007
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymesMaria Laura Belladonna, Paolo Puccetti, Ciriana Orabona, et al.International Journal of Tryptophan Research : IJTR|February 17, 2023
Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and MiceElisa Proietti, Renske W M Pauwels, Annemarie C de Vries, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2012
A GpC-rich oligonucleotide acts on plasmacytoid dendritic cells to promote immune suppressionClaudia Volpi, Francesca Fallarino, Roberta Bianchi, et al.Pageof 7